#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4352897	A	Cytotoxicity against human HepG2.2.15 cells assessed as cell viability measured after 72 hrs by MTT assay	Homo sapiens	28		cell-based format	Scientific Literature
2.	ALA4352898	B	Inhibition of capsid protein in Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in viral DNA level supplemented with fresh medium containing compound every 2 days and measured after 6 days by RT-PCR analysis relative to control	Hepatitis B virus	28		cell-based format	Scientific Literature
3.	ALA4352899	B	Inhibition of capsid protein in Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in viral DNA level at 4 uM supplemented with fresh medium containing compound every 2 days and measured after 6 days by RT-PCR analysis	Hepatitis B virus	7		cell-based format	Scientific Literature
4.	ALA4352900	T	Selectivity index, ratio of CC50 for human HepG2.2.15 cells to IC50 for capsid protein in Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in viral DNA level		7		cell-based format	Scientific Literature
5.	ALA4352901	B	Inhibition of capsid protein in lamivudine/entecavir-resistant Hepatitis B virus harboring rtL180M/rtM204V/rt184L mutant infected in human HepG2.2.15 cells assessed as reduction in viral DNA level at 4 uM measured after 72 hrs by PCR analysis relative to control	Hepatitis B virus	2		cell-based format	Scientific Literature
6.	ALA4352902	B	Inhibition of capsid protein in wild type Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction of viral DNA level at 4 uM measured after 72 hrs by PCR analysis relative to control	Hepatitis B virus	2		cell-based format	Scientific Literature
7.	ALA4352907	B	Inhibition of capsid protein in lamivudine/entecavir-resistant Hepatitis B virus harboring rtL180M/rtM204V/rt184L mutant infected in human HepG2.2.15 cells assessed as reduction in viral DNA level measured after 72 hrs by PCR analysis	Hepatitis B virus	3		cell-based format	Scientific Literature
8.	ALA4352908	T	Selectivity index, ratio of CC50 for human HepG2.2.15 cells to IC50 for capsid protein in lamivudine/entecavir-resistant Hepatitis B virus harboring rtL180M/rtM204V/rt184L mutant infected in human HepG2.2.15 cells assessed as reduction in viral DNA level		3		cell-based format	Scientific Literature
9.	ALA5158574	T	Cytotoxicity against human HepG2 2.2.15 cells infected with Hepatitis B virus assessed as reduction in cell growth by CCK8 assay	Homo sapiens	19		cell-based format	Scientific Literature
10.	ALA5158576	T	Cytotoxicity against human HepG2 2.2.15 cells infected with Hepatitis B virus assessed as inhibition of cell growth at 0.4 uM incubated for 6 days by RT PCR analysis relative to control	Homo sapiens	19		cell-based format	Scientific Literature
11.	ALA5158577	F	Antiviral activity against Hepatitis B virus infected in human HepG2 2.2.15 cells assessed as inhibition of DNA replication	Homo sapiens	8		cell-based format	Scientific Literature
12.	ALA5158578	T	Selectivity index, ratio of CC50 for human HepG2.2.2.15 cells to IC50 for Hepatitis B virus infected in human HepG2.2.2.15 cells		8		cell-based format	Scientific Literature